CSIMarket
 

Lifeloc Technologies Inc   (LCTC)
Other Ticker:  
 

Lifeloc Technologies Inc 's Working Capital Per Sales

LCTC's Working Capital and Revenue growth

 



LCTC Working Capital Per Revenue (Mar 31 2024)
I. Quarter
(Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
Y / Y Working Capital Change -15.3 % -3.79 % 6.37 % 6.3 % 0.83 %
Y / Y Revenue Change -0.51 % 3.78 % 32.66 % 4.6 % 0.18 %
Working Capital Per Revenue 0.51 0.53 0.54 0.57 0.57
Working Capital Per Revenue Ranking # 1845 # 1843 # 1354 # 1949 # 1575
Seq. Working Capital Change -12.4 % -6.1 % 1.17 % 1.79 % -0.5 %
Seq. Revenue Change -1.63 % -18.78 % 18.21 % 5.35 % 2.61 %





Comment on LCTC's Working Capital Per Revenue in the first quarter 2024
Lifeloc Technologies Inc 's Working Capital Per Revenue in the Q1 2024 sequentially fell to 0.51 below the company average. Due to decrease of revenue year on year in the first quarter 2024 by -0.51%.

Within Healthcare sector 60 other companies have achieved lower Working Capital Per Revenue during the Q1 2024. While Working Capital Per Revenue total ranking has deteriorated in the first quarter 2024, compared to previous quarter from 1843 to 1845.
Working Capital Per Revenue Ranking
Within: No.
Industry # 2
Sector # 61
S&P 500 # 1845


Working Capital Per Revenue Statistics
High Average Low
0.72
0.53
0.44
(Mar 31 2021)   (June 30. 2015)



Financial Statements
Lifeloc Technologies Inc 's Working Capital $ 4 Millions Visit LCTC's Balance sheet
Lifeloc Technologies Inc 's Revenues $ 2 Millions Visit LCTC's Income Statement
Where are LCTC's Sales coming from? Visit LCTC's Sales by Geography




Companies with similar Average Working Capital Per Revenue for 12 months ending Mar 31 2024, within Healthcare Sector Working Capital Per Revenue
Sarepta Therapeutics Inc   1.38 
Moderna Inc   1.38 
Icad Inc  1.35 
Si bone inc   1.32 
Karyopharm Therapeutics Inc   1.30 
Sonendo Inc   1.27 
Repligen Corp  1.25 
Telesis Bio Inc   1.23 
Revance Therapeutics Inc   1.23 
Twist Bioscience Corporation  1.22 
Clearpoint Neuro Inc   1.22 
Shockwave Medical Inc   1.18 
Apellis Pharmaceuticals Inc   1.17 
Neuropace Inc   1.16 
Silk Road Medical Inc   1.15 
Regeneron Pharmaceuticals Inc   1.15 
Y mabs Therapeutics inc   1.15 
Fonar Corporation  1.13 
Axonics Inc   1.13 
Intra cellular Therapies Inc   1.12 
Orthopediatrics Corp  1.09 
Prophase Labs Inc   1.07 
United Therapeutics Corporation  1.07 
Biocryst Pharmaceuticals Inc   1.06 
Ardelyx Inc   1.06 
Maravai Lifesciences Holdings Inc   1.05 
Cutera Inc   1.05 
Orasure Technologies Inc  1.05 
Neuroone Medical Technologies Corp  1.04 
Mangoceuticals Inc   1.03 
Date modified: 2024-09-02T11:06:20+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com